implementation
london
lynch
omitted
synthetase
51i
rarely
dates
malar
estimate
characterized
serological
winnie
rate
164l
joseph
wwarn
294
knowledge
discontinuation
112
170
impacts
232
207
delay
references
white
discernibly
perfect
driven
both
rev
posteriori
184
antifolate
181
melissa
nat
third
profound
disease
928
haplotype
age
tests
results
antimalarial
generating
165
chemother
pota
emmanuel
documenting
2015
emerging
252
polymorphisms
studies
105
moi
genes
chloroquine
tanzania
ji
surveyor
widespread
act
exact
college
multiclonal
pq
129
168
124
understanding
identified
microscopy
ariey
populations
running
combination
underway
n86
md
regimen
increase
published
sampling
ra
past
southwestern
224
under
279
nsobya
sequence
earlier
determined
263
medical
192
msp2
5london
legac
continued
selects
concentration
199
resistance
273
131
as
grants
pathway
assessment
whole
org
limitations
1246y
yielding
samuel
sequenced
finger
148
consequences
157
differ
consistent
179
compared
did
m472v
258
more
cross
patterns
141
report
248
acknowledgments
540
bites
seen
drug
only
234
288
193
119
415
isolates
concern
numerous
associated
205
modify
kihihi
file
least
less
59r
1959
almost
110
toward
polymorphism
fluorescent
anti
2013
264
individuals
some
notably
detected
163
circumvent
patrick
older
pc
k76t
infect
pj
8425
captures
8845
genotypes
ranging
nagongera
exclusively
186
genetic
plowe
increasingly
recent
dorsey
institutes
followed
warranted
pcr
cohort
uncorrected
marker
render
437
figure
annual
226
chemoprevention
http
may
different
1466
3d7
number
mpimbaza
237
population
test
300
identical
mutant
therefore
yeka
dhfr
pressure
also
geographic
i164l
documented
epidemiological
statistical
harvard
126
176
256
clarified
comparisons
adoke
1598
bryan
extracted
page
angella
215
june
assessed
combining
time
374
evaluating
phone
apparent
270
has
convincing
103
1034c
grant
143
markedly
uncomplicated
amaratunga
therapy
261
rare
march
randomized
via
discarding
133
transmission
mediating
ai075045
credible
southwest
placing
gama
recurrent
placed
setting
thank
285
outstanding
context
nature
nyd
supported
there
180
anemia
2center
authors
african
interest
propeller
therapies
clinical
muhindo
137
word
additional
187
vivo
212
denotes
fisher
477
text
540e
suggesting
per
interval
principally
257
indicated
interplay
important
samples
175
all
648
ambiguity
pairwise
361
202
total
parasite
154
including
control
sciences
mit
artemisinin
boston
m472i
altered
flegg
multiple
amplified
methods
n51i
nuwagaba
decreasing
e0118901
details
significant
characterization
asua
247
kavishe
147
opposite
117
electrophoresis
ronald
suggest
staff
plos
broadly
effects
242
symptoms
entomological
every
intermediate
national
135
145
y184f
care
sequences
dynamics
kakuru
slow
bukirwa
study
152
about
254
aimee
changing
technical
200
handful
109
monitoring
evident
collection
pyrimethamine
treatment
templates
hyg
central
seems
dihydroartemisinin
316
fax
nag
lead
a581g
microbiol
2005
versus
furthermore
reported
hubbard
surveys
mk
whether
was
reductase
minor
tropical
countries
228
bars
121
jinja
available
however
c59r
antifolates
437g
site
year
preventive
considered
title
will
infected
211
future
218
160
numbers
189
putative
107
221
markers
blood
folate
antimicrob
increased
locus
intensity
replacement
thus
similar
rotating
indicate
same
pfmdr1
182
167
274
250
separate
130
276
clin
offer
2010
urgent
140
www
eastern
diseases
children
240
230
115
single
fitness
239
269
363
temporal
clearly
rwanda
limited
within
prevalent
obtained
5649
engl
ai089674
frequency
infections
equal
broad
206
used
background
mediator
randomly
institute
ca
baliraine
point
aq
small
197
allele
through
while
gene
truncated
150
245
decreased
see
a578s
jagannathan
communicable
values
dept
159
162
adult
al
walukuba
266
inoculation
estimates
dihydropteroate
reciprocal
nankabirwa
169
190
stephen
172
223
sl
interestingly
216
𝑚𝑎𝑥
spectrum
hiv
123
mutations
gregson
team
modifications
2003
alleles
pearce
medicine
shown
encodes
steadily
super
wild
experimentally
sensitivity
identify
sulfamethoxazole
treated
polyclonal
categorizing
nd
76t
challenges
return
artemether
episode
tororo
272
nfd
drugs
191
𝑚𝑖𝑛
262
uncommon
primarily
table
225
142
nsanzabana
david
128
rates
278
cv
research
considering
survey
ja
1486
overcome
trop
prior
thesing
arinaitwe
335
kenya
approach
efficacy
elsewhere
222
prevention
rather
district
217
158
581g
recommended
ar
132
key
appear
geometric
piperaquine
measures
344
selective
circumventing
mbogo
209
who
previously
505
149
increases
participation
factors
eddington
near
calculation
111
many
author
n86y
139
1246
178
san
gupta
aminoquinolines
glycoprotein
113
cameroon
account
pressures
parameter
conrad
2014
dihydrofolate
suggested
containing
contrast
hygiene
molecular
our
293
soon
267
great
supplementary
classified
particular
than
pfdhps
233
2000
mediated
280
data
after
amodiaquine
nankoberanyi
kamya
new
respectively
183
362
genomes
204
generated
generally
changed
253
probability
assay
mutation
most
greenhouse
had
nested
much
incomplete
236
correlation
analyses
k540e
calculable
malarial
into
260
probably
144
86y
177
capillary
k563e
uganda
increasing
analysis
paper
kampala
sarah
a569s
227
pharmacol
s1034c
applied
modulate
financial
non
enzymes
missing
infectious
likely
102
leclair
259
positive
philip
249
makerere
pregnant
colors
witkowski
loci
studying
course
mol
214
accounts
other
significance
2564
asterisks
d1246
university
runs
another
125
2008
artemisinins
well
potential
dirichlet
linked
acts
156
196
118
kanungu
prick
supplement
194
derived
emergence
1025
communities
andrew
244
error
surveyed
lumefantrine
comparative
now
100
their
235
265
171
2012
but
over
prevent
ucsf
polymorphic
administrative
evaluations
especially
evidence
footnote
based
lake
priority
estimation
greater
108n
bonferroni
separately
showed
𝑀𝑂𝐼
represent
reaction
domain
contributed
trends
use
6department
staedke
dried
yielded
disequilibrium
282
walakira
regaining
mean
parasitemia
surveillance
edu
np
gw
166
slatkin
134
abstract
1134
185
microsphere
sp
127
studied
153
101
type
regardless
246
south
falciparum
occur
dis
marked
136
116
001
responses
calculated
intervals
selected
k76
schoolchildren
differences
person
supplemental
line
108
604
a613s
helpful
does
outside
process
155
trials
gel
conflicts
period
although
2006
198
support
february
mapping
malaria
during
229
greatly
rosenthal
equally
recently
moses
317
demonstrating
multiplicity
they
pfdhfr
fairly
fn
210
filter
analyzed
main
271
mail
excellent
complexities
pfcrt
isolated
model
ma
addition
sulfadoxine
1042d
outcomes
342
california
frequencies
confounding
sites
120
taylor
213
161
s108t
improved
utilizing
varied
tumwebaze
accounting
impact
random
prevalence
ruhamyankaka
med
detection
remains
transporters
kigozi
strain
become
pregnancy
consideration
might
stable
treat
corresponding
355
discussion
195
d1246y
collaboration
second
counts
174
work
188
conducted
linkage
three
reference
april
settings
two
each
count
africa
243
106
203
plot
mixed
n1042d
268
full
238
accompanied
one
estimated
usa
synonymous
146
164
chan
january
genotype
378
practices
94143
sample
infection
genotyping
unexpected
rd
conferring
keywords
collected
151
138
cambridge
francisco
changes
areas
described
optimization
bampiga
dha
evolution
haplotypes
255
spread
superiority
yet
between
intermittent
trial
women
public
households
agents
amplifications
parasites
using
since
advantage
3department
joaniter
tukwasibwe
dna
122
4makerere
plasmodium
2004
homologue
decade
level
resistant
evolutionary
173
uk
sectional
complicated
219
ntege
220
ugandan
rosenthal3
v555a
challenge
transporter
useless
change
a437g
summary
sizes
286
mediators
trimethoprim
bacterial
000
275
association
laufer
pure
251
k13
take
school
omara
once
3018
kaaya
present
mediate
208
114
common
health
241
genet
104
mechanisms
victoria
regimens
artesunate
201
categories
short
victor
2016
231
correction
contribution
spots
ligase
niger
malawi
noted
not
years
loss
277
selection
remained
standard
statistically
high
demonstrated
first
quotients